Biomedical Engineering Reference
In-Depth Information
Pelengaris S, Littlewood T, Khan M, Elia G, Evan G. Reversible activation of c-Myc in skin:
induction of a complex neoplastic phenotype by a single oncogenic lesion. Mol Cell
1999;3:565-577.
Perez-Losada J, Balmain A. Stem cell hierarchy in skin cancer. Nat Rev Cancer
2003;3:434-443.
Pierce GB, Dixon FJ. The demonstration of teratogenesis by metamorphosis of multipoten-
tial cells. Cancer 1959;12:573-583.
Pierce GB, Spears WC. Tumors as caricatures of the process of tissue renewal: prospects for
therapy by directing differentiation. Cancer Res 1988;48:1196-1204.
Pierce GB, Wallace C. Differentiation of malignant to benign cells. Cancer Res
1971;31:127-134. AN AACR SCIENTIFIC LANDMARK.
Pierce GM, Dixon FJ, Verney E. Teratocarcinogenic and tissue forming potentials of the cell
types comprising neoplastic embryoid bodies. Lab Invest 1960;9:583-602.
Pierce GB, Shikes R, Fink LM. Cancer: A Problem of Developmental Biology. Prentice Hall
Inc., Engelwood Cliffs, NJ, 1978, pp 1-242.
Pirollo KF, Chang EH. Targeted delivery of small interfering RNA: approaching effective
cancer therapies. Cancer Res 2008;68:1247-1250.
Pirollo KF, Rait A, Zhou Z, Hwang SH, Dagata JA, Zon G, et al. Materializing the potential
of small interfering RNA via tumor-targeting nanodelivery system. Cancer Res
2007;67:2938-2943.
Pott P. Chirurgical Observations Relative to the Cataract, the Polypus of the Nose, the
Cancer of the Scrotum, the Different Kinds of Ruptures, and the Mortification of the
Toes and Feet. Hawes, Clarke and Colllins, London, 1775.
Potten CS, Morris RJ. Epithelial stem cells in vivo. J Cell Sci 1988;10(Suppl):45-62.
Potter M. Percivall Pott's contribution to cancer research. NCI Monogr 1963;10:1-13.
Prehn RT. The role of mutation in the new cancer paradigm. Cancer Cell Int 2005;5:9-13.
Puck TT, Marcus PI. A rapid method of viable cell titration and clone production with HeLa
cells in tissue culture: use of x-irradiated cells to supply conditioning factors. PNAS
1955;41:432-437.
Puttini M, Coluccia ML, Boschelli F, et al. In vitro and in vivo activity of SKI-606, a novel
Src-Abl inhibitor, against Imatinib-resistant Bcr-Abl+ neoplastic cells. Cancer Res
2006;66:11314-11322.
Recamier JCA. Recherches sur the traitement du cancer: par la compressionmethodique simple
ou combinee, et sur l'histoire general de la meme maladie. 2 vols, Gabon, Paris, 1829.
Reinhard MC, Goltz HL, Warner SC. Further studies on the quantitative determination of
the growth of a transplantable mouse adenocarcinoma. Cancer Res 1952a;5:102-106.
Reinhard MC, Goltz HL, Warner SG, Mirand EC. Growth rate and percentage takes
following inoculation of known numbers of viable mouse tumor cells. Exp Med Surg
1952b;10:254.
Remak R. Ein beitrag zur entwickelungsgeschichte der krebshaften geschwulste. Deut Klin
1854;6:170-174.
Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells.
Nature 2001;414:105-111.
Rich JN. Cancer stem cells in radiation resistance. Cancer Res 2007;67:8980-8984.
Rippert H. Geschwulstelehre fur Aerzte und Studierende. Bonn, 1904.
Rous P. A sarcoma of the fowl transmissible by an agent separable from the tumor cells. J Exp
Med 1911;13:397-411. AN AACR SCIENTIFIC LANDMARK.
Rous P, Kidd JG. Conditional neoplasms and subthreshold neoplastic states. J Exp Med
1942;73:365-372.
Rowley JD. Nonrandom chromosomal abnormalities in hematologic disorders of man. Proc
Natl Acad Sci USA 1975;72:152-156.
Rygaard J, Povlsen CO. Heterotransplantation of a human malignant tumour to ''Nude'' mice.
Acta Pathol Microbiol Scand 1969;77:758-760. AN AACR SCIENTIFIC LANDMARK.
